Evidence map›Paper›PMID 34084009›Full record

ArticleJournal of cutaneous and aesthetic surgery

Fractional Carbon Dioxide Laser versus Fractional Carbon Dioxide Laser with Autologous Intralesional Platelet-rich Plasma in the Treatment of Stable, Non-segmental Vitiligo: A Randomized Comparative Study.

Annie Raizada, Maitreyee Panda, Bhabani Stp Singh, Bikash R Kar

Open access · diamondAbstract read
In one paragraph

Article in Journal of cutaneous and aesthetic surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Annie RaizadaDepartment of DVL, Institute of Medical Sciences & SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, Odisha, India.
Maitreyee PandaDepartment of DVL, Institute of Medical Sciences & SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, Odisha, India.
Bhabani Stp SinghDepartment of DVL, Institute of Medical Sciences & SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, Odisha, India.
Bikash R KarDepartment of DVL, Institute of Medical Sciences & SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, Odisha, India.
Siksha O Anusandhan University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe treatment of vitiligo is often challenging and requires a multi-modality approach. Fractional carbon dioxide (FCO AIMS AND

objectiveThe aim of this study was to compare the efficacy and safety of FCO SETTINGS AND

designA prospective, randomized, comparative, open-label interventional study was carried out for a period of 18 months from December 2017 to June 2019, at a tertiary care hospital. MATERIALS AND

methodsSeventy patients with stable, NSV were assessed for eligibility; 66 patients were randomized equally into two groups. Group A received treatment with FCO

resultsVASI score reduction was significantly more in the Group A with (mean ± standard deviation [SD]) 9.5 ± 0.22, 5.8 ± 1.12, and 3.6 ± 1.81 as compared to Group B 11.9 ± 2.83, 9.9 ± 3.11, and 8.9 ± 3.46 at each subsequent follow-up visits, respectively. Side effects such as burning sensation, erythema, and crusting were seen less frequently and lasted for a short period in Group A in comparison to those in Group B.

conclusionCombination of FCO

Indexed as

Autologous platelet-rich plasmafractional carbon dioxide lasernon-segmental vitiligoVASI score

Identifiers

PMID34084009
PMCPMC8149972
OpenAlexW3160899797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.